Steven Levine, PhD

Sr. Director, Virtual Human Modeling | Dassault Systèmes

Steven Levine, PhD is the Sr. Director of Virtual Human Modeling at Dassault Systèmes. Dr. Levine has more than 30 years of experience in the development of computational science and engineering software. He is Founder and Executive Director of the Living Heart Project. Prior to his current role, he was Chief Strategy Officer for SIMULIA, the simulation brand within Dassault Systèmes. Dr. Levine was elected into the College of Fellows in the American Institute for Medical and Biological Engineering (AIMBE) in 2017 and holds a PhD in Materials Science from Rutgers University. He began his career in health tech at Accelrys, where he led Corporate Development prior to its acquisition by Dassault Systèmes in 2014.

All Sessions by Steven Levine, PhD

  • May 1, 2024

    Wednesday

  • 11:30 AM  - 12:15 PM
    In tandem with AI, the transformative potential of computational modeling and simulation is set to revolutionize clinical trials, providing a compelling vision of how these advanced digital technologies can minimize risks, cut costs, and expedite the product approval process.

    Medical device development has already employed modeling and simulation for product development and early-stage product testing. The latest advances now allow for continued operations in virtual environments throughout the clinical trial stage. This includes generating virtual patient cohorts for treatment arms and synthetic patients for control arms, offering an innovative approach to trial design, and streamlining the assessment of novel treatments.

    This session will explore the convergence of these technologies and present compelling evidence of progress, including recent collaborative efforts with the FDA in developing a groundbreaking blueprint for utilizing these advanced approaches, representing a significant step towards a more efficient and patient-centric future in device development.

    Sponsored By
    New Product Development
    Where
    161




Share

Steven Levine, PhD